Filed: 2026-04-08 AccNo: 0001493152-26-015662 Size: 250 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - MAIA Biotechnology, Inc. - 8.01 / 9.01
Filed:
2026-04-16
AccNo:
0001493152-26-016989
Size:
243 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/16 13:25 UTC
首次发现04/16 13:26 UTC
热度104.2
重要度52
情绪0.00
站内整理正文
优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 682 字符
Form 8-K - Current report: SEC Accession No. 0001493152-26-016989
Filing Date: 2026-04-16
Accepted: 2026-04-16 09:25:30
Documents: 13
Period of Report: 2026-04-16
Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
MAIA Biotechnology, Inc. (Filer) CIK : 0001878313 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 26865930 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | form8-k.htm iXBRL | 8-K
2 | EX-99.1 | ex99-1.htm | EX-99.1
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC
4 | XBRL SCHEMA FILE | maia-20260416.xsd | EX-101.SCH
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇